Last updated
Vanguard Health Care Index Fund (VHT)
Price 265.37元
List of Constituents
VHT Constituents. Through this analysis, you can identify the individual stocks held by the ETF and further analyze their fair value and value range.
| Rank | Ticker | Name | Ratio |
|---|---|---|---|
| 1 | LLY | Eli Lilly & Co. | 11.08% |
| 2 | UNH | UnitedHealth Group Inc. | 8.59% |
| 3 | ABBV | AbbVie Inc. | 5.39% |
| 4 | JNJ | Johnson & Johnson | 4.81% |
| 5 | MRK | Merck & Co. Inc. | 4.09% |
| 6 | TMO | Thermo Fisher Scientific Inc. | 3.45% |
| 7 | ABT | Abbott Laboratories | 3.26% |
| 8 | ISRG | Intuitive Surgical Inc. | 2.95% |
| 9 | AMGN | Amgen Inc. | 2.84% |
| 10 | DHR | Danaher Corp. | 2.71% |
| 11 | PFE | Pfizer Inc. | 2.65% |
| 12 | BSX | Boston Scientific Corp. | 2.04% |
| 13 | VRTX | Vertex Pharmaceuticals Inc. | 2.03% |
| 14 | SYK | Stryker Corp. | 2.02% |
| 15 | MDT | Medtronic plc | 1.89% |
| 16 | BMY | Bristol-Myers Squibb Co. | 1.87% |
| 17 | GILD | Gilead Sciences Inc. | 1.83% |
| 18 | ANTM | Anthem Inc. | 1.56% |
| 19 | REGN | Regeneron Pharmaceuticals Inc. | 1.5% |
| 20 | CI | Cigna Corp. | 1.48% |
| 21 | ZTS | Zoetis Inc. | 1.35% |
| 22 | CVS | CVS Health Corp. | 1.17% |
| 23 | HCA | HCA Healthcare Inc. | 1.17% |
| 24 | BDX | Becton Dickinson and Co. | 1.12% |
| 25 | MCK | McKesson Corp. | 1.07% |
| 26 | ABC | AmerisourceBergen Corp. Class A | 0.68% |
| 27 | EW | Edwards Lifesciences Corp. | 0.67% |
| 28 | GEHC | GE HealthCare Technologies Inc. | 0.63% |
| 29 | A | Agilent Technologies Inc. | 0.63% |
| 30 | IQV | IQVIA Holdings Inc. | 0.62% |
| 31 | RMD | ResMed Inc. | 0.59% |
| 32 | IDXX | IDEXX Laboratories Inc. | 0.56% |
| 33 | ALNY | Alnylam Pharmaceuticals Inc. | 0.56% |
| 34 | CNC | Centene Corp. | 0.55% |
| 35 | VEEV | Veeva Systems Inc. Class A | 0.53% |
| 36 | HUM | Humana Inc. | 0.51% |
| 37 | MTD | Mettler-Toledo International Inc. | 0.46% |
| 38 | DXCM | DexCom Inc. | 0.46% |
| 39 | CAH | Cardinal Health Inc. | 0.44% |
| 40 | BIIB | Biogen Inc. | 0.42% |
| 41 | ILMN | Illumina Inc. | 0.38% |
| 42 | WST | West Pharmaceutical Services Inc. | 0.37% |
| 43 | ZBH | Zimmer Biomet Holdings Inc. | 0.36% |
| 44 | STE | STERIS plc | 0.36% |
| 45 | COO | Cooper Cos. Inc. | 0.35% |
| 46 | WAT | Waters Corp. | 0.32% |
| 47 | LH | Labcorp Holdings Inc. | 0.32% |
| 48 | MOH | Molina Healthcare Inc. | 0.31% |
| 49 | HOLX | Hologic Inc. | 0.31% |
| 50 | BAX | Baxter International Inc. | 0.3% |
| 51 | MRNA | Moderna Inc. | 0.29% |
| 52 | DGX | Quest Diagnostics Inc. | 0.28% |
| 53 | PODD | Insulet Corp. | 0.27% |
| 54 | UTHR | United Therapeutics Corp. | 0.26% |
| 55 | THC | Tenet Healthcare Corp. | 0.25% |
| 56 | PKI | PerkinElmer Inc. | 0.24% |
| 57 | ALGN | Align Technology Inc. | 0.24% |
| 58 | AVTR | Avantor Inc. | 0.23% |
| 59 | VTRS | Viatris Inc. | 0.23% |
| 60 | NTRA | Natera Inc. | 0.23% |
| 61 | BMRN | BioMarin Pharmaceutical Inc. | 0.21% |
| 62 | EXAS | Exact Sciences Corp. | 0.21% |
| 63 | INCY | Incyte Corp. | 0.2% |
| 64 | NBIX | Neurocrine Biosciences Inc. | 0.2% |
| 65 | UHS | Universal Health Services Inc. Class B | 0.2% |
| 66 | TECH | Bio-Techne Corp. | 0.19% |
| 67 | CTLT | Catalent Inc. | 0.18% |
| 68 | SOLV | Solventum Corp. | 0.18% |
| 69 | RPRX | Royalty Pharma plc Class A | 0.17% |
| 70 | EHC | Encompass Health Corp. | 0.17% |
| 71 | INSM | Insmed Inc. | 0.17% |
| 72 | TFX | Teleflex Inc. | 0.16% |
| 73 | PCVX | Vaxcyte Inc. | 0.16% |
| 74 | CRL | Charles River Laboratories International Inc. | 0.15% |
| 75 | HSIC | Henry Schein Inc. | 0.15% |
| 76 | ENSG | Ensign Group Inc. | 0.15% |
| 77 | SRPT | Sarepta Therapeutics Inc. | 0.14% |
| 78 | PEN | Penumbra Inc. | 0.14% |
| 79 | MEDP | Medpace Holdings Inc. | 0.14% |
| 80 | EXEL | Exelixis Inc. | 0.14% |
| 81 | CHE | Chemed Corp. | 0.13% |
| 82 | LNTH | Lantheus Holdings Inc. | 0.13% |
| 83 | ITCI | Intra-Cellular Therapies Inc. | 0.13% |
| 84 | RGEN | Repligen Corp. | 0.12% |
| 85 | BIO | Bio-Rad Laboratories Inc. Class A | 0.12% |
| 86 | HQY | HealthEquity Inc. | 0.12% |
| 87 | DVA | DaVita Inc. | 0.12% |
| 88 | VKTX | Viking Therapeutics Inc. | 0.12% |
| 89 | JAZZ | Jazz Pharmaceuticals plc | 0.11% |
| 90 | MASI | Masimo Corp. | 0.11% |
| 91 | HALO | Halozyme Therapeutics Inc. | 0.11% |
| 92 | GKOS | Glaukos Corp. | 0.11% |
| 93 | BRKR | Bruker Corp. | 0.1% |
| 94 | ELAN | Elanco Animal Health Inc. | 0.1% |
| 95 | INSP | Inspire Medical Systems Inc. | 0.1% |
| 96 | GMED | Globus Medical Inc. | 0.1% |
| 97 | MMSI | Merit Medical Systems Inc. | 0.1% |
| 98 | RVMD | REVOLUTION Medicines Inc. | 0.1% |
| 99 | CYTK | Cytokinetics Inc. | 0.09% |
| 100 | BPMC | Blueprint Medicines Corp. | 0.09% |
| 101 | Organon & Co. | 0.08% | |
| 102 | Dentsply Sirona Inc. | 0.08% | |
| 103 | IONS | Ionis Pharmaceuticals Inc. | 0.08% |
| 104 | CORT | Corcept Therapeutics Inc. | 0.08% |
| 105 | DOCS | Doximity Inc. Class A | 0.08% |
| 106 | Acadia Healthcare Co. Inc. | 0.07% | |
| 107 | Option Care Health Inc. | 0.07% | |
| 108 | Alkermes plc | 0.07% | |
| 109 | ICU Medical Inc. | 0.07% | |
| 110 | Ultragenyx Pharmaceutical Inc. | 0.07% | |
| 111 | Integer Holdings Corp. | 0.07% | |
| 112 | RDNT | RadNet Inc. | 0.07% |
| 113 | Crinetics Pharmaceuticals Inc. | 0.07% | |
| 114 | PROCEPT BioRobotics Corp. | 0.07% | |
| 115 | ROIV | Roivant Sciences Ltd. | 0.07% |
| 116 | Envista Holdings Corp. | 0.06% | |
| 117 | Perrigo Co. plc | 0.06% | |
| 118 | Haemonetics Corp. | 0.06% | |
| 119 | CRISPR Therapeutics AG | 0.06% | |
| 120 | Axonics Modulation Technologies Inc. | 0.06% | |
| 121 | Select Medical Holdings Corp. | 0.06% | |
| 122 | Prestige Consumer Healthcare Inc. | 0.06% | |
| 123 | Denali Therapeutics Inc. | 0.06% | |
| 124 | Krystal Biotech Inc. | 0.06% | |
| 125 | MDGL | Madrigal Pharmaceuticals Inc. | 0.06% |
| 126 | TG Therapeutics Inc. | 0.06% | |
| 127 | Avidity Biosciences Inc. | 0.06% | |
| 128 | ADMA Biologics Inc. | 0.06% | |
| 129 | Biohaven Ltd. | 0.06% | |
| 130 | Amedisys Inc. | 0.05% | |
| 131 | Neogen Corp. | 0.05% | |
| 132 | LivaNova plc | 0.05% | |
| 133 | PTC Therapeutics Inc. | 0.05% | |
| 134 | CRVL | CorVel Corp. | 0.05% |
| 135 | Apellis Pharmaceuticals Inc. | 0.04% | |
| 136 | Premier Inc. Class A | 0.04% | |
| 137 | iRhythm Technologies Inc. | 0.04% | |
| 138 | Omnicell Inc. | 0.04% | |
| 139 | Arrowhead Pharmaceuticals Inc. | 0.04% | |
| 140 | Inari Medical Inc. | 0.04% | |
| 141 | Evolent Health Inc. Class A | 0.04% | |
| 142 | RCM | R1 RCM Inc. | 0.04% |
| 143 | Enovis Corp. | 0.04% | |
| 144 | CONMED Corp. | 0.04% | |
| 145 | Amicus Therapeutics Inc. | 0.04% | |
| 146 | Twist Bioscience Corp. | 0.04% | |
| 147 | Xenon Pharmaceuticals Inc. | 0.04% | |
| 148 | Addus HomeCare Corp. | 0.04% | |
| 149 | TransMedics Group Inc. | 0.04% | |
| 150 | Veracyte Inc. | 0.04% | |
| 151 | Apollo Medical Holdings Inc. | 0.04% | |
| 152 | Agios Pharmaceuticals Inc. | 0.04% | |
| 153 | Axsome Therapeutics Inc. | 0.04% | |
| 154 | Bridgebio Pharma Inc. | 0.04% | |
| 155 | Sotera Health Co. | 0.04% | |
| 156 | Merus NV | 0.04% | |
| 157 | Hims & Hers Health Inc. | 0.04% | |
| 158 | NUVL | Nuvalent Inc. Class A | 0.04% |
| 159 | Catalyst Pharmaceuticals Inc. | 0.04% | |
| 160 | Rhythm Pharmaceuticals Inc. | 0.04% | |
| 161 | Arcellx Inc. | 0.04% | |
| 162 | QuidelOrtho Corp. | 0.04% | |
| 163 | Guardant Health Inc. | 0.04% | |
| 164 | Novocure Ltd. | 0.03% | |
| 165 | Teladoc Health Inc. | 0.03% | |
| 166 | Tandem Diabetes Care Inc. | 0.03% | |
| 167 | Brooks Automation Inc. | 0.03% | |
| 168 | Privia Health Group Inc. | 0.03% | |
| 169 | Beam Therapeutics Inc. | 0.03% | |
| 170 | BioCryst Pharmaceuticals Inc. | 0.03% | |
| 171 | 10X Genomics Inc. Class A | 0.03% | |
| 172 | Patterson Cos. Inc. | 0.03% | |
| 173 | ACADIA Pharmaceuticals Inc. | 0.03% | |
| 174 | AtriCure Inc. | 0.03% | |
| 175 | Supernus Pharmaceuticals Inc. | 0.03% | |
| 176 | Myriad Genetics Inc. | 0.03% | |
| 177 | Ligand Pharmaceuticals Inc. | 0.03% | |
| 178 | Celldex Therapeutics Inc. | 0.03% | |
| 179 | Amphastar Pharmaceuticals Inc. | 0.03% | |
| 180 | Vericel Corp. | 0.03% | |
| 181 | Iovance Biotherapeutics Inc. | 0.03% | |
| 182 | Surgery Partners Inc. | 0.03% | |
| 183 | MannKind Corp. | 0.03% | |
| 184 | LeMaitre Vascular Inc. | 0.03% | |
| 185 | NeoGenomics Inc. | 0.03% | |
| 186 | Kymera Therapeutics Inc. | 0.03% | |
| 187 | National HealthCare Corp. | 0.03% | |
| 188 | Keros Therapeutics Inc. | 0.03% | |
| 189 | SpringWorks Therapeutics Inc. | 0.03% | |
| 190 | Clover Health Investments Corp. Class A | 0.03% | |
| 191 | Immunovant Inc. | 0.03% | |
| 192 | Protagonist Therapeutics Inc. | 0.03% | |
| 193 | Akero Therapeutics Inc. | 0.03% | |
| 194 | RxSight Inc. | 0.03% | |
| 195 | UFP Technologies Inc. | 0.03% | |
| 196 | Ideaya Biosciences Inc. | 0.03% | |
| 197 | Geron Corp. | 0.03% | |
| 198 | Dyne Therapeutics Inc. | 0.03% | |
| 199 | Vera Therapeutics Inc. Class A | 0.03% | |
| 200 | Longboard Pharmaceuticals Inc. | 0.03% | |
| 201 | Scholar Rock Holding Corp. | 0.03% | |
| 202 | AMN Healthcare Services Inc. | 0.02% | |
| 203 | Integra LifeSciences Holdings Corp. | 0.02% | |
| 204 | Intellia Therapeutics Inc. | 0.02% | |
| 205 | Progyny Inc. | 0.02% | |
| 206 | STAAR Surgical Co. | 0.02% | |
| 207 | Arvinas Inc. | 0.02% | |
| 208 | Tilray Inc. | 0.02% | |
| 209 | Novavax Inc. | 0.02% | |
| 210 | Xencor Inc. | 0.02% | |
| 211 | Schrodinger Inc./United States | 0.02% | |
| 212 | Cassava Sciences Inc. | 0.02% | |
| 213 | Phreesia Inc. | 0.02% | |
| 214 | Certara Inc. | 0.02% | |
| 215 | Harmony Biosciences Holdings Inc. | 0.02% | |
| 216 | Travere Therapeutics Inc. | 0.02% | |
| 217 | US Physical Therapy Inc. | 0.02% | |
| 218 | Alignment Healthcare Inc. | 0.02% | |
| 219 | Syndax Pharmaceuticals Inc. | 0.02% | |
| 220 | Rocket Pharmaceuticals Inc. | 0.02% | |
| 221 | Aurinia Pharmaceuticals Inc. | 0.02% | |
| 222 | CareDx Inc. | 0.02% | |
| 223 | Innoviva Inc. | 0.02% | |
| 224 | Brookdale Senior Living Inc. | 0.02% | |
| 225 | Collegium Pharmaceutical Inc. | 0.02% | |
| 226 | Viridian Therapeutics Inc. | 0.02% | |
| 227 | Recursion Pharmaceuticals Inc. Class A | 0.02% | |
| 228 | CryoLife Inc. | 0.02% | |
| 229 | Nurix Therapeutics Inc. | 0.02% | |
| 230 | Pennant Group Inc. | 0.02% | |
| 231 | Amneal Pharmaceuticals Inc. | 0.02% | |
| 232 | Janux Therapeutics Inc. | 0.02% | |
| 233 | Tarsus Pharmaceuticals Inc. | 0.02% | |
| 234 | MEDNAX Inc. | 0.02% | |
| 235 | Fortrea Holdings Inc. | 0.02% | |
| 236 | Ardelyx Inc. | 0.02% | |
| 237 | Mirum Pharmaceuticals Inc. | 0.02% | |
| 238 | ANI Pharmaceuticals Inc. | 0.02% | |
| 239 | MoonLake Immunotherapeutics Class A | 0.02% | |
| 240 | Dynavax Technologies Corp. | 0.02% | |
| 241 | Harrow Inc. | 0.02% | |
| 242 | Apogee Therapeutics Inc. | 0.02% | |
| 243 | Edgewise Therapeutics Inc. | 0.02% | |
| 244 | Ocular Therapeutix Inc. | 0.02% | |
| 245 | Soleno Therapeutics Inc. | 0.02% | |
| 246 | WaVe Life Sciences Ltd. | 0.02% | |
| 247 | agilon health Inc. | 0.01% | |
| 248 | Pacira BioSciences Inc. | 0.01% | |
| 249 | Prothena Corp. plc | 0.01% | |
| 250 | Sage Therapeutics Inc. | 0.01% | |
| 251 | Maravai LifeSciences Holdings Inc. Class A | 0.01% | |
| 252 | Pacific Biosciences of California Inc. | 0.01% | |
| 253 | Revance Therapeutics Inc. | 0.01% | |
| 254 | Relay Therapeutics Inc. | 0.01% | |
| 255 | Vir Biotechnology Inc. | 0.01% | |
| 256 | AdaptHealth Corp. | 0.01% | |
| 257 | Ironwood Pharmaceuticals Inc. Class A | 0.01% | |
| 258 | CryoPort Inc. | 0.01% | |
| 259 | Cross Country Healthcare Inc. | 0.01% | |
| 260 | Owens & Minor Inc. | 0.01% | |
| 261 | Verve Therapeutics Inc. | 0.01% | |
| 262 | Arcus Biosciences Inc. | 0.01% | |
| 263 | Establishment Labs Holdings Inc. | 0.01% | |
| 264 | Avid Bioservices Inc. | 0.01% | |
| 265 | Cytek Biosciences Inc. | 0.01% | |
| 266 | Emergent BioSolutions Inc. | 0.01% | |
| 267 | Allogene Therapeutics Inc. | 0.01% | |
| 268 | Varex Imaging Corp. | 0.01% | |
| 269 | OPKO Health Inc. | 0.01% | |
| 270 | Avanos Medical Inc. | 0.01% | |
| 271 | Anavex Life Sciences Corp. | 0.01% | |
| 272 | Kura Oncology Inc. | 0.01% | |
| 273 | REGENXBIO Inc. | 0.01% | |
| 274 | DocGo Inc. | 0.01% | |
| 275 | uniQure NV | 0.01% | |
| 276 | Fulgent Genetics Inc. | 0.01% | |
| 277 | Adaptive Biotechnologies Corp. | 0.01% | |
| 278 | BioLife Solutions Inc. | 0.01% | |
| 279 | Alphatec Holdings Inc. | 0.01% | |
| 280 | Mesa Laboratories Inc. | 0.01% | |
| 281 | Cerus Corp. | 0.01% | |
| 282 | Simulations Plus Inc. | 0.01% | |
| 283 | Enhabit Inc. | 0.01% | |
| 284 | ImmunityBio Inc. | 0.01% | |
| 285 | Cogent Biosciences Inc. | 0.01% | |
| 286 | OrthoPediatrics Corp. | 0.01% | |
| 287 | HealthStream Inc. | 0.01% | |
| 288 | Sangamo Therapeutics Inc. | 0.01% | |
| 289 | Theravance Biopharma Inc. | 0.01% | |
| 290 | Castle Biosciences Inc. | 0.01% | |
| 291 | SI-BONE Inc. | 0.01% | |
| 292 | Butterfly Network Inc. | 0.01% | |
| 293 | Sana Biotechnology Inc. | 0.01% | |
| 294 | Alector Inc. | 0.01% | |
| 295 | AnaptysBio Inc. | 0.01% | |
| 296 | MaxCyte Inc. | 0.01% | |
| 297 | Replimune Group Inc. | 0.01% | |
| 298 | Surmodics Inc. | 0.01% | |
| 299 | Health Catalyst Inc. | 0.01% | |
| 300 | Arcturus Therapeutics Holdings Inc. | 0.01% | |
| 301 | SIGA Technologies Inc. | 0.01% | |
| 302 | Quanterix Corp. | 0.01% | |
| 303 | GoodRx Holdings Inc. Class A | 0.01% | |
| 304 | Community Health Systems Inc. | 0.01% | |
| 305 | Orthofix Medical Inc. | 0.01% | |
| 306 | Phibro Animal Health Corp. Class A | 0.01% | |
| 307 | OraSure Technologies Inc. | 0.01% | |
| 308 | Nuvation Bio Inc. | 0.01% | |
| 309 | Erasca Inc. | 0.01% | |
| 310 | Stoke Therapeutics Inc. | 0.01% | |
| 311 | MiMedx Group Inc. | 0.01% | |
| 312 | Humacyte Inc. | 0.01% | |
| 313 | Monte Rosa Therapeutics Inc. | 0.01% | |
| 314 | Phathom Pharmaceuticals Inc. | 0.01% | |
| 315 | Zimvie Inc. | 0.01% | |
| 316 | Y-mAbs Therapeutics Inc. | 0.01% | |
| 317 | Embecta Corp. | 0.01% | |
| 318 | Pliant Therapeutics Inc. | 0.01% | |
| 319 | Altimmune Inc. | 0.01% | |
| 320 | Entrada Therapeutics Inc. | 0.01% | |
| 321 | OmniAb Inc. | 0.01% | |
| 322 | 89bio Inc. | 0.01% | |
| 323 | Day One Biopharmaceuticals Inc. | 0.01% | |
| 324 | Liquidia Technologies Inc. | 0.01% | |
| 325 | Disc Medicine Inc. | 0.01% | |
| 326 | Evolus Inc. | 0.01% | |
| 327 | Enliven Therapeutics Inc. | 0.01% | |
| 328 | ACELYRIN Inc. | 0.01% | |
| 329 | Fluidigm Corp. | 0.01% | |
| 330 | Cullinan Therapeutics Inc. | 0.01% | |
| 331 | Arcutis Biotherapeutics Inc. | 0.01% | |
| 332 | Praxis Precision Medicines Inc. | 0.01% | |
| 333 | Spyre Therapeutics Inc. | 0.01% | |
| 334 | Immunome Inc. | 0.01% | |
| 335 | EyePoint Pharmaceuticals Inc. | 0.01% | |
| 336 | Mind Medicine MindMed Inc. | 0.01% | |
| 337 | Zymeworks Inc. | 0.01% | |
| 338 | Olema Pharmaceuticals Inc. | 0.01% | |
| 339 | Astria Therapeutics Inc. | 0.01% | |
| 340 | ORIC Pharmaceuticals Inc. | 0.01% | |
| 341 | ARS Pharmaceuticals Inc. | 0.01% | |
| 342 | Savara Inc. | 0.01% | |
| 343 | Cargo Therapeutics Inc. | 0.01% | |
| 344 | Korro Bio Inc. | 0.01% | |
| 345 | GRAIL Inc. | 0.01% | |
| 346 | Kiniksa Pharmaceuticals International plc Class A | 0.01% | |
| 347 | Fate Therapeutics Inc. | 0% | |
| 348 | FibroGen Inc. | 0% | |
| 349 | Nevro Corp. | 0% | |
| 350 | ModivCare Inc. | 0% | |
| 351 | Zentalis Pharmaceuticals Inc. | 0% | |
| 352 | Editas Medicine Inc. | 0% | |
| 353 | American Well Corp. Class A | 0% | |
| 354 | Seres Therapeutics Inc. | 0% | |
| 355 | Enanta Pharmaceuticals Inc. | 0% | |
| 356 | Cutera Inc. | 0% | |
| 357 | Agenus Inc. | 0% | |
| 358 | Nektar Therapeutics Class A | 0% | |
| 359 | Accolade Inc. | 0% | |
| 360 | Vanda Pharmaceuticals Inc. | 0% | |
| 361 | 2seventy bio Inc. | 0% | |
| 362 | Gossamer Bio Inc. | 0% | |
| 363 | Multiplan Corp. | 0% | |
| 364 | AngioDynamics Inc. | 0% | |
| 365 | Ventyx Biosciences Inc. | 0% | |
| 366 | Inovio Pharmaceuticals Inc. | 0% | |
| 367 | Coherus Biosciences Inc. | 0% | |
| 368 | Paragon 28 Inc. | 0% | |
| 369 | RAPT Therapeutics Inc. | 0% | |
| 370 | Inogen Inc. | 0% | |
| 371 | Heron Therapeutics Inc. | 0% | |
| 372 | Atea Pharmaceuticals Inc. | 0% | |
| 373 | Cara Therapeutics Inc. | 0% | |
| 374 | Treace Medical Concepts Inc. | 0% | |
| 375 | Pulmonx Corp. | 0% | |
| 376 | iTeos Therapeutics Inc. | 0% | |
| 377 | Ocugen Inc. | 0% | |
| 378 | ATAI Life Sciences NV | 0% | |
| 379 | CareMax Inc. | 0% | |
| 380 | Seer Inc. Class A | 0% | |
| 381 | Repare Therapeutics Inc. | 0% | |
| 382 | PMV Pharmaceuticals Inc. | 0% | |
| 383 | Tango Therapeutics Inc. | 0% | |
| 384 | ALX Oncology Holdings Inc. | 0% | |
| 385 | IGM Biosciences Inc. | 0% | |
| 386 | MacroGenics Inc. | 0% | |
| 387 | MeiraGTx Holdings plc | 0% | |
| 388 | Organogenesis Holdings Inc. Class A | 0% | |
| 389 | Century Therapeutics Inc. | 0% | |
| 390 | Aclaris Therapeutics Inc. | 0% | |
| 391 | Senseonics Holdings Inc. | 0% | |
| 392 | Aerovate Therapeutics Inc. | 0% | |
| 393 | Akoya Biosciences Inc. | 0% | |
| 394 | HilleVax Inc. | 0% | |
| 395 | Outset Medical Inc. | 0% | |
| 396 | 23andMe Holding Co. Class A | 0% | |
| 397 | Definitive Healthcare Corp. Class A | 0% | |
| 398 | Biomea Fusion Inc. | 0% | |
| 399 | Amylyx Pharmaceuticals Inc. | 0% | |
| 400 | Aldeyra Therapeutics Inc. | 0% | |
| 401 | Lyell Immunopharma Inc. | 0% | |
| 402 | Terns Pharmaceuticals Inc. | 0% | |
| 403 | Bionano Genomics Inc. | 0% | |
| 404 | Cabaletta Bio Inc. | 0% | |
| 405 | Mural Oncology plc | 0% | |
| 406 | Prime Medicine Inc. | 0% | |
| 407 | SCILEX HOLDING CO - RESTRICTED LINE | 0% | |
| 408 | 4D Molecular Therapeutics Inc. | 0% | |
| 409 | Dianthus Therapeutics Inc. | 0% |
Disclaimer
1. The information provided is for reference only and does not constitute any guarantee of profits or specific stock and price point recommendations.
2. The information is not complete; for comprehensive data, please refer to the relevant websites.
3. All stock market data analyses are subject to survivorship bias.
